Consistent with melanoma publications, most of the glioma studies postulated that the decrease activity of PTEN is related to tumor progression and that the activation of the mTOR pathway was able to override BRAFv600e-induced senescence [15,33,60]. The gene discussed is MTOR; the disease is neoplasm.